Invited speakers ECTH 2025
Sophie Susen, France
Preliminary lecture title: Von Willebrand Disease (VWD)
Sophie Susen is Professor of Medicine (MD) at the department of Hematology of Lille University Hospital in Lille (France) and heads the department of Hemostasis and Transfusion. She is board-certified to practice biology, hematology and transfusion. Her Ph.D and postdoctoral fellowship was based on the role of von Willebrand factor in the context of vascular injury.
Her research activity is performed at Inserm Unit 1011 (Lille Nord de France University). She heads a research team working on the role of Von Willebrand Factor and blood flow via different approaches. She is also the national coordinator of reference center for VWD and national coordinator of the French network of rare bleeding disorders treating centers.
Laura Gutiérrez, Spain
Preliminary lecture title: Clinical applications of platelet proteomics
Laura Gutiérrez obtained her Bachelor’s degree in Biology (Fundamental Biology and Biotechnology) at the Faculty of Biology, Universidad de Oviedo (Spain), in 1998. She obtained an MSc in Biotechnology in 2000 at De Montfort University (Leicester, United Kingdom, with Distinction), having completed her Master’s dissertation under the supervision of Dr A. de Klein from the Genetics Department of the ErasmusMC (Rotterdam, the Netherlands).
She then joined the Cell Biology Department in ErasmusMC as a PhD researcher, and obtained her PhD in 2005 (thesis title: “Studies on Gata1: Cell Cycle, Survival and Differentiation”), under the supervision of Professor F. Grosveld and co-supervised by Professor J. Philipsen.
Jan Blatný, Czech Republic
Preliminary lecture title: Current management of haemophilia in children
Jan Blatný, MD, PhD, is Consultant Haematologist at the Department of Paediatric Haematology and Biochemistry and the Director of the Haemophilia Comprehensive Care Centre of University Hospital Brno. He is also an Associate Professor of Paediatrics at Masaryk University in Brno, Czech Republic and serves also as a Clinical Lead for Internal Medicine Out-patient services in the new generation hospital Bory, Bratislava, Slovakia.
His research interests encompass paediatric haematology, thrombosis and haemostasis, and life-threatening bleeding. Dr Blatný is a member of numerous national and international haematology organizations.
Nick van Es, The Netherlands
Preliminary lecture title: Cancer and thrombosis
Nick van Es is an internist specialized in Vascular Medicine at the Amsterdam University Medical Center. He defended his PhD-thesis “Cancer and thrombosis: improvements in strategies for prediction, diagnosis, and treatment” cum laude in 2017 supervised by Prof. Saskia Middeldorp and Prof. Patrick Bossuyt. He was a research trainee at the The Ottawa Hospital supervised by Prof. Marc Carrier and was trained as a Clinical Epidemiologist by Prof. Patrick Bossuyt.
His current research focuses on prediction, diagnosis, and treatment of venous thromboembolism, with a particular interest in cancer-associated thrombosis. He has co-authored more than 100 peer-reviewed publications and has established collaborations with various national and international experts in the field.
Milan Macek, Czech Republic
Preliminary lecture title: From Mendel to medical genetics
Professor Milan Macek Jr. MD, DSc is the chairman of the largest academic medical / molecular genetics institution in the Czech Republic – Department of Biology and Medical Genetics of Charles University Prague-2nd School of Medicine and Motol University Hospital, and of the National Coordination Centre for Rare Diseases (www.nkcvo.cz; NKCVO) responsible for implementation of the ten year national strategy on rare diseases and resulting three national action plans. In addition, he is chairing the national Rare Disease Taskforce at the Ministry of Health. In this capacity his institute has been serving as a “clearing centre” for the dissemination of knowledge gathered within various international projects on rare disease-related research and diagnostics (e.g. EuroGentest.org, RD-Connect.eu, Solve-RD.eu, Norway Grants) to partners in Eastern Europe, Transcaucasia and the Middle East. In this capacity Prof. Macek is also the Czech National coordinator of Orpha.net. In his capacity as chairman of NKCVO he assured that since 2017 Czechia is ranking first within EU13 in terms of participation in European Reference Networks (ERN) for rare diseases.
Thomas Vanassche, Belgium
Preliminary lecture title: Clinical Thrombosis management
Christoph Binder, Austria
Preliminary lecture title: Age-related somatic mutations, atherosclerosis and cardiovascular death
Christoph J. Binder (born 1973) received his MD degree from the University of Vienna, Austria, in 1997 and his PhD degree in Molecular Pathology from the University of California San Diego (UCSD), USA, in 2002. Following postdoctoral training at the Department of Medicine of UCSD, he established his own research group at the Department of Laboratory Medicine of the Medical University of Vienna in 2005. In 2009, he was appointed Full Professor of Atherosclerosis Research at the Medical University of Vienna. He is a specialist in Laboratory Medicine and currently Deputy Head of the Department of Laboratory Medicine at the Medical University of Vienna. Between 2006 until 2021 he was Principal Investigator at the Center for Molecular Medicine of the Austrian Academy of Sciences.
Zsuzsa Bagoly, Hungary
Preliminary lecture title: Genetic risk factors in ischemic stroke treatment
Zsuzsa Bagoly received a medical degree from the University of Debrecen, Faculty of Medicine, Hungary in 2004. She obtained her PhD in clinical hemostasis in 2008 and became board certified in clinical laboratory medicine in 2011. She is currently an associate professor at the Department of Laboratory Medicine, University of Debrecen. Her research areas include basic and clinical research in fibrinolysis, factor XIII, stroke, and rare hemostasis disorders.
She is currently the Chair of the International Society on Thrombosis and Haemostasis (ISTH) Scientific and Standardization Committee on Factor XIII and Fibrinogen, and the President of the Hungarian Society on Thrombosis and Haemostasis. She has been an invited speaker at several meetings, including state-of-the-art presentations at ISTH and the International Society on Fibrinolysis and Proteolysis (ISFP) meetings. In recent years, she received several prestigious scientific awards, including the L’Oreal UNESCO Prize for Women in Science in 2020.
Cédric Hermans, Belgium
Preliminary lecture title: Haemophilia diagnosis and
treatment
Cedric Hermans currently heads the Division of Haematology, the Hemostasis and Thrombosis Unit as well as the Hemophilia Center of the Saint-Luc University Hospital in Brussels, Belgium.
He was appointed Full Professor at the Medical School of the Catholic University of Louvain in 2012 and Vice-Dean in 2015.
Professor Hermans has (co)-authored more than 360 original articles in international journals and is a member of several scientific societies and international advisory boards and collaborative research projects.